Mining the genomes of exceptional responders.
Where this comes from
- Record sourced from PubMed, PMID 25688402.
- Also identified by DOI 10.1038/nrc3723.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The National Cancer Institute of the United States recently announced a major new initiative in understanding the genomes or, more broadly, the molecular phenotypes of exceptional responders. What can we expect to learn from exceptional responders? What are the potential benefits, and how do we approach studying them?
Medical subject headings
- Molecular Targeted Therapy
- Neoplasms